These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1829921)

  • 21. Enhancement of chlorambucil cytotoxicity by combination with flavone acetic acid in a murine tumour.
    Parkins CS; Chadwick JA; Chaplin DJ
    Anticancer Res; 1994; 14(4A):1603-8. PubMed ID: 7979193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flavone acetic acid increases the cytotoxicity of mitomycin C when combined with hyperthermia.
    Takeuchi H; Baba H; Maehara Y; Sugimachi K; Newman RA
    Cancer Chemother Pharmacol; 1996; 38(1):1-8. PubMed ID: 8603441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor-alpha suppresses the regrowth of fractionated irradiated endothelial cells in vitro.
    Lin PS; Ho KC; Tsai S
    Cancer Biother Radiopharm; 1996 Aug; 11(4):251-7. PubMed ID: 10851545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic alkalinization inhibits the ability of flavone acetic acid to augment natural killer activity, induce cytokine gene expression, and synergize with interleukin 2 for the treatment of murine renal cancer.
    Futami H; Hornung RL; Back TT; Bull R; Gruys E; Wiltrout RH
    Cancer Res; 1990 Dec; 50(24):7926-31. PubMed ID: 2253233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ability of coumarin-, flavanon- and flavonol-analogues of flavone acetic acid to stimulate human monocytes.
    Barbera M; Caputo A; Zampiron A; Gobbi S; Rampa A; Bisi A; Carrara M
    Oncol Rep; 2008 Jan; 19(1):187-96. PubMed ID: 18097594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status.
    Bibby MC; Phillips RM; Double JA; Pratesi G
    Br J Cancer; 1991 Jan; 63(1):57-62. PubMed ID: 1989665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of environmental conditions (pH, oxygenation and temperature) on the cytotoxicity of flavone acetic acid and its dimethylaminoethyl ester.
    Teicher BA; Holden SA; Rudolph MB; Sotomayor EA; Herman TS
    Int J Hyperthermia; 1991; 7(6):905-15. PubMed ID: 1806644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative regulatory role of PI3-kinase in TNF-induced tumor necrosis.
    Matschurat S; Blum S; Mitnacht-Kraus R; Dijkman HB; Kanal L; De Waal RM; Clauss M
    Int J Cancer; 2003 Oct; 107(1):30-7. PubMed ID: 12925953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of 5,6-dimethylxanthenone-4-acetic acid on tumour necrosis factor production by human immune cells.
    Patel S; Parkin SM; Bibby MC
    Anticancer Res; 1997; 17(1A):141-50. PubMed ID: 9066644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid.
    Cao Z; Joseph WR; Browne WL; Mountjoy KG; Palmer BD; Baguley BC; Ching LM
    Br J Cancer; 1999 May; 80(5-6):716-23. PubMed ID: 10360649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of flavone acetic acid on endothelial cell proliferation: evidence for antiangiogenic properties.
    Lindsay CK; Gomez DE; Thorgeirsson UP
    Anticancer Res; 1996; 16(1):425-31. PubMed ID: 8615648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells.
    Conway EM; Bach R; Rosenberg RD; Konigsberg WH
    Thromb Res; 1989 Feb; 53(3):231-41. PubMed ID: 2718149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small-molecule cytokine inducers causing tumor necrosis.
    Baguley BC
    Curr Opin Investig Drugs; 2001 Jul; 2(7):967-75. PubMed ID: 11757800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress contributes to the anti-proliferative effects of flavone acetic acid on endothelial cells.
    Harris SR; Panaro NJ; Thorgeirsson UP
    Anticancer Res; 2000; 20(4):2249-54. PubMed ID: 10953282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells.
    Mechtcheriakova D; Schabbauer G; Lucerna M; Clauss M; De Martin R ; Binder BR; Hofer E
    FASEB J; 2001 Jan; 15(1):230-242. PubMed ID: 11149911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antitumour agent 5,6-dimethylxanthenone-4-acetic acid acts in vitro on human mononuclear cells as a co-stimulator with other inducers of tumour necrosis factor.
    Philpott M; Ching LM; Baguley BC
    Eur J Cancer; 2001 Oct; 37(15):1930-7. PubMed ID: 11576850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol ester.
    Archipoff G; Beretz A; Freyssinet JM; Klein-Soyer C; Brisson C; Cazenave JP
    Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):679-84. PubMed ID: 1847620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antitumour activity of new derivatives of flavone-8-acetic acid (FAA). Part 3: 2-Heteroaryl derivatives.
    Aitken RA; Bibby MC; Bielefeldt F; Double JA; Laws AL; Mathieu AL; Ritchie RB; Wilson DW
    Arch Pharm (Weinheim); 1998 Dec; 331(12):405-11. PubMed ID: 9923196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased plasma serotonin following treatment with flavone-8-acetic acid, 5,6-dimethylxanthenone-4-acetic acid, vinblastine, and colchicine: relation to vascular effects.
    Baguley BC; Zhuang L; Kestell P
    Oncol Res; 1997; 9(2):55-60. PubMed ID: 9167186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of in vitro cytotoxicity of mouse peritoneal exudate cells by flavone acetic acid (NSC 347512).
    Ching LM; Baguley BC
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1521-5. PubMed ID: 3181272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.